Hydromorphone Hydrochloride Injection — FDA Drug Shortage

Current — Fresenius Kabi USA, LLC

The FDA lists a drug shortage record for Hydromorphone Hydrochloride Injection (injection) from Fresenius Kabi USA, LLC with status Current. The shortage was first posted on 10/31/2017.

Shortage Details

Status
Current
Company
Fresenius Kabi USA, LLC
Package NDC
63323-851-50
Dosage Form
Injection
Presentation
Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 63323-851-50)
Initial Posting
10/31/2017
Revised Date